Hengehold Capital Management LLC Has $537,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Hengehold Capital Management LLC increased its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 30.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,340 shares of the conglomerate’s stock after buying an additional 544 shares during the period. Hengehold Capital Management LLC’s holdings in Danaher were worth $537,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Coronation Fund Managers Ltd. increased its stake in shares of Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares during the period. Public Sector Pension Investment Board grew its holdings in Danaher by 119.8% in the 2nd quarter. Public Sector Pension Investment Board now owns 19,503 shares of the conglomerate’s stock valued at $4,873,000 after buying an additional 10,628 shares in the last quarter. APG Asset Management US Inc. increased its position in Danaher by 4.4% during the 2nd quarter. APG Asset Management US Inc. now owns 211,565 shares of the conglomerate’s stock worth $51,730,000 after buying an additional 8,908 shares during the period. APG Asset Management N.V. lifted its holdings in shares of Danaher by 13.6% during the second quarter. APG Asset Management N.V. now owns 531,544 shares of the conglomerate’s stock worth $123,915,000 after buying an additional 63,712 shares in the last quarter. Finally, Daymark Wealth Partners LLC boosted its position in shares of Danaher by 3.0% in the second quarter. Daymark Wealth Partners LLC now owns 16,498 shares of the conglomerate’s stock valued at $4,122,000 after acquiring an additional 485 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on DHR. Royal Bank of Canada dropped their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Guggenheim started coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. Stifel Nicolaus lifted their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Stephens restated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Finally, Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $285.55.

View Our Latest Stock Analysis on Danaher

Danaher Stock Up 0.6 %

NYSE:DHR opened at $245.73 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a one year low of $225.42 and a one year high of $281.70. The firm’s 50 day simple moving average is $234.90 and its 200 day simple moving average is $253.47. The company has a market cap of $177.49 billion, a PE ratio of 46.90, a P/E/G ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.02 earnings per share. On average, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is 20.61%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.